FDA
approval
· 2022-01-24
FDA Approved: LANTHANUM CARBONATE — Original Application (Cipla USA Inc.)
Summary
FDA approved Cipla USA Inc.'s generic lanthanum carbonate (original application) for the treatment of hyperphosphatemia in adults with chronic kidney disease on…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LANTHANUM CARBONATE (LANTHANUM CARBONATE)